Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)
Status:
Recruiting
Trial end date:
2023-11-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Fecal Microbiota Therapy (FMT) is effective
vs. placebo in the prevention of C. difficile infection recurrence.